Browse Related Topics For:

Off-Label Promotion

62
FDA
57
Pharmaceutical
44
Prescription Drugs
43
Off-Label Use
36
FDCA
35
First Amendment
35
Pharmaceutical Manufacturers
22
Free Speech
22
Marketing
20
Medical Devices
19
Commercial Speech
19
Misbranding
18
Amarin
18
Drug Manufacturers
18
False Claims Act
12
Healthcare
9
DOJ
9
Preliminary Injunctions
9
Qui Tam
8
Caronia
8
Physicians
8
Whistleblowers
6
FDA Approval
6
Medicare
6
Popular
5
Device Manufacturers
5
Fraud
5
Johnson & Johnson
5
Kickbacks
5
Preemption
4
Anti-Kickback Statute
4
Compliance
4
Enforcement Actions
4
FCA
4
GlaxoSmithKline
4
HHS
4
Hospitals
4
Life Sciences
4
Medicaid
4
RICO
4
SCOTUS
3
Class Action
3
Criminal Prosecution
3
Draft Guidance
3
Enforcement
3
Failure To Warn
3
False Advertising
3
FFDCA
3
Healthcare Professionals
3
InterMune
3
Misleading Statements
3
OIG
2
Abbott Laboratories
2
Advertising
2
Affordable Care Act
2
Allergan Inc
2
Biotechnology
2
Cephalon
2
Choice-of-Law
2
Class Certification
2
Clinical Trials
2
Commercial Marketing
2
Data Security
2
Dismissals
2
FCC
2
FCPA
2
FTC
2
FTCA
2
Generic Drugs
2
Health Care Providers
2
Indictments
2
Insurers
2
Labeling
2
Manufacturers
2
Medicare Part D
2
Medtronic
2
Misrepresentation
2
Novartis
2
Orphan Drugs
2
Pleading Standards
2
Predominance Requirement
2
Proposed Amendments
2
Public Health
2
Relators
2
SEC
2
Settlement
2
Warning Labels
2
Wire Fraud
1
21st Century Cures Initiative
1
340B
1
3D Printing
1
510(k) RTA
1
Actual Injuries
1
Alzheimer's
1
Amazon
1
Amgen
1
Amgen Inc. v Connecticut Retirement Plans
1
Amicus Briefs
1
ANDA
1
Anti-Money Laundering
1
Appeals
1
Appellate Review
1
Arbitration
1
Below-Cost Pricing
1
Bifurcation
1
Birth Defects
1
Board of Directors
1
Botox
1
Brand
1
Bristol-Myers Squibb
1
Celebrity Endorsements
1
CEOs
1
CFPB
1
Civil Monetary Penalty
1
CMS
1
Compelled Speech
1
Contract Drafting
1
Corporate Counsel
1
Corporate Integrity Agreement
1
Corporate Officers
1
Criminal Conspiracy
1
Cross-Border Transactions
1
Cybersecurity
1
Data Brokers
1
Data Privacy
1
Daubert Standards
1
Declination
1
Dietary Supplements
1
Discovery
1
Do Not Disturb
1
Durable Medical Equipment
1
Evidence
1
Expert Witness
1
False Billing
1
False Statements
1
FDA Warning Letters
1
Federal Question Jurisdiction
1
Fifth Amendment
1
First-to-File
1
Foreign Financial Accounts
1
FTC v Actavis
1
Grable Factors
1
GRAS
1
Hackers
1
Healthcare Facilities
1
Home Health Care
1
Honest Services Fraud
1
Hospice
1
HRSA
1
Humana
1
ICD-10
1
Illegal Gratuities
1
Injunctions
1
Injunctive Relief
1
Innovator Liability
1
Instagram
1
International Arbitration
1
Interstate Commerce
1
Ireland
1
Janssen Pharmaceuticals
1
Jury Trial
1
Jury Verdicts
1
Kaiser Permanente
1
Kim Kardashian
1
Lanham Act
1
Leave to Amend
1
Legislative Committees
1
Libor
1
License Agreements
1
Litigation Hold
1
Mass Tort Litigation
1
Merck
1
Morgan Stanley
1
Motion to Compel
1
Multidistrict Litigation
1
Northern Ireland
1
Nursing Homes
1
OMB
1
OPDP
1
Par Pharmaceutical
1
Patents
1
Payday Loans
1
Pending Legislation
1
Personal Liability
1
Personally Identifiable Information
1
Pfizer
1
Pharmacies
1
Pleadings
1
PLIVA v Mensing
1
Prescription Drug Coverage
1
Privacy Policy
1
Product Defects
1
Product Labels
1
Professional Liability
1
Public Disclosure
1
Putative Class Actions
1
Regulatory Agenda
1
Regulatory Standards
1
Ripeness
1
Rule 23
1
Safe Harbors
1
Sanctions
1
Schering-Plough
1
Sealed Records
1
Section 5
1
Securities Fraud
1
SNDAs
1
Social Media
1
State Law Tort Claims
1
Statute of Limitations
1
Strategic Enforcement Plan
1
Strict Liability
1
Takeda Pharmaceuticals
1
TCPA
1
Third-Party
1
Trademarks
1
Travelers
1
TRICARE
1
Unfair or Deceptive Trade Practices
1
Wrongful Death